Methimazole
- Product NDC
- 70934-622
- 11-digit product format
- 709340622
- Labeler code
- 70934
- Product ID
- 70934-622_acaeb8c3-7e69-6adc-e053-2995a90ac0b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methimazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA040547
- Marketing category
- ANDA
- Marketing start
- 2020-03-19
- Marketing end
- 0000-00-00
- Substance
- METHIMAZOLE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-622-30 | Methimazole | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-622 | METHIMAZOLE TABLET [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 1 | Legacy NDC, 1 package rows | 20200813_acae35a6-dea2-3fa9-e053-2a95a90a3a4d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-622-30 | 70934062230 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-622-30) | 30 tablet | 2020-03-19 | 0000-00-00 | No | No | Current |